Safety, tolerability, and efficacy of LiRIS 400 mg in women with interstitial cystitis/bladder pain syndrome with or without Hunner lesions.
Robert EvansAlfred KohanRobert MoldwinDaniel RadeckiTill GeibKenneth M PetersPublished in: Neurourology and urodynamics (2021)
These studies did not demonstrate a treatment effect of LiRIS 400 mg compared with placebo, either in patients with IC/BPS with HL, or in those without HL.